Navigation Links
Mylan Launches First Generic Version of Femara® Tablets
Date:4/25/2011

PITTSBURGH, April 25, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Letrozole Tablets USP, 2.5 mg, under a previously announced settlement and license agreement with Novartis. Mylan was the first company to have filed a substantially complete ANDA containing a Paragraph IV certification for Letrozole Tablets and will market the product with a period of exclusivity.

Letrozole Tablets are the generic version of Novartis' Femara® Tablets, an adjuvant treatment for postmenopausal women with hormone receptor-positive early stage breast cancer. This product had U.S. sales of approximately $682 million for the 12 months ending Dec. 31, 2010, according to IMS Health.

Currently, Mylan has 165 ANDAs pending FDA approval representing $98.5 billion in annual sales, according to IMS Health. Forty-six of these pending ANDAs are potential first-to-file opportunities, representing $25.9 billion in annual brand sales, for the 12 months ending June 30, 2010, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
2. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
3. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
4. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
5. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
6. Mylan Receives Approval for Generic Version of GoLytely(R)
7. Mylan Declares Quarterly Preferred Stock Dividend
8. Mylan Pre-Pays All Scheduled 2011 Term-Loan Borrowings
9. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
10. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
11. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 1, 2015 Prismic Pharmaceuticals, Inc., a specialty ... foods, today announced the election of Joseph J. ... its Board of Directors. Commenting on the ... Moriarty , Chairman and CEO of Prismic, stated, "We ... Martin Simonetti have accepted our invitation to join ...
(Date:7/1/2015)... , July 1, 2015  Imprimis Pharmaceuticals, Inc. ... on the development and commercialization of proprietary compounded ... ring The Nasdaq stock market closing bell on ... growing success of its Go Dropless™ campaign since ... cataract procedures are performed annually in the U.S. ...
(Date:7/1/2015)... -- ExeGi Pharma, a company focused on developing and ... it has been granted a product license by the ... to sell Visbiome™ in Canada . ... Claudio De Simone , MD, PhD and has been ... recently signed an exclusive agreement with ExeGi Pharma to ...
Breaking Medicine Technology:Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 2ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 3
... Mass., March 18, 2011 Cytel ... implementation services and software, proudly announced today the ... Baker as Vice President, Clinical Research Services. ... demonstrated biopharmaceutical development leadership at some of the ...
... family of Midland, Michigan have a new lease on ... and Mike ALL underwent Roux-en-Y bariatric surgery ... to offer this life-changing surgery. The surgeries were performed ... The family has lost 445 pounds, and counting. ...
Cached Medicine Technology:Cytel Hires Biopharmaceutical Development Veteran Jim Baker to Support Expansion of its Clinical Research Offerings 2Midland Family Undergoes Bariatric Surgery at Hurley Medical Center--Loses 445 Pounds & Counting—Tells their Life-Saving Story to Media on March 18, 2011 2
(Date:7/2/2015)... ... ... Every year, DUI arrests and fatalities spike on the 4th of July. In fact, because ... when it comes to being on the road. According to attorney David J. Maloney ... of all highway deaths between 2007 and 2011 were caused by drunk driving over the ...
(Date:7/2/2015)... ... , ... no secret that what we consume can have an effect on the body. And during the ... or perhaps even undernourished if not eating enough of the right foods, as well as drinking ... of year to overdo it on the food front as well, with sweet treats like ice ...
(Date:7/2/2015)... ... July 02, 2015 , ... Cs &A, ... Semiconductor Timing announced the release and publication of their newest offering to complement ... publication and Newsletter. , Designed in support of coverage for the full ...
(Date:7/1/2015)... Los Angeles, CA (PRWEB) , ... July 01, 2015 , ... ... enjoy the great outdoors. Yet, in many Middle-Eastern countries like Saudi Arabia and Dubai, ... entirely to relax in more temperate climates. Celebrity dentist Dr. Sam Saleh of ORA ...
(Date:7/1/2015)... York, New York (PRWEB) , ... July 01, ... ... injury lawsuit filed against the manufacturers of Levaquin ( http://www.injurybeacon.com/levaquin/lawsuit/ ) has granted ... U.S. District Court, Southern District of West Virginia on June 26th, the Court ...
Breaking Medicine News(10 mins):Health News:Attorney David Maloney Stresses Safety through Sobriety 2Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3
... In-Q-Tel Investment in Sonitus Medical Accelerates Development of ... the TeethSAN MATEO, Calif., May 26 Sonitus ... world,s first non-surgical and removable hearing device to ... strategic investment and technology advancement agreement with In-Q-Tel, ...
... on the cholesterol-lowering drugs , , MONDAY, May 25 (HealthDay News) ... risk of a second stroke, new research shows. , The ... a 35 percent lower incidence of second strokes and a ... compared to those who didn,t, according to a report in ...
... the L.A. MarathonLOS ANGELES, May 25 Today,s Los Angeles ... infamous and hugely-plumped characters from the Foster Farms television commercials. ... pass themselves off as fresh, natural and never "plumped" Foster ... entered the duo as part of its "Say No To ...
... Vienna, Austria: The relationship between the dental disease ... for several years. Although a genetic link ... Now, for the first time, scientists have discovered a ... the annual conference of the European Society of Human ...
... of trials finds Avastin with chemo doubles odds ... of the drug bevacizumab (Avastin) in combination with chemotherapy ... patients, new research has found. , These perforations are ... small intestine or large bowel. , Bevacizumab is designed ...
... woman,s death in New York City raises national toll to ... been made towards developing a viable H1N1 swine flu vaccine, ... Prevention saying this week that they have two promising candidate ... 50-year-old woman died of swine flu in New York City ...
Cached Medicine News:Health News:Sonitus Medical Secures Strategic Investment and Technology Advancement Agreement From In-Q-Tel 2Health News:Sonitus Medical Secures Strategic Investment and Technology Advancement Agreement From In-Q-Tel 3Health News:Statins Can Help Prevent Second Stroke 2Health News:Statins Can Help Prevent Second Stroke 3Health News:Scientists find shared genetic link between the dental disease periodontitis and heart attack 2Health News:Cancer Drug May Boost Risk of Gastrointestinal Perforation 2Health News:Viable Swine Flu Shot Closer to Reality 2Health News:Viable Swine Flu Shot Closer to Reality 3Health News:Viable Swine Flu Shot Closer to Reality 4Health News:Viable Swine Flu Shot Closer to Reality 5Health News:Viable Swine Flu Shot Closer to Reality 6Health News:Viable Swine Flu Shot Closer to Reality 7Health News:Viable Swine Flu Shot Closer to Reality 8Health News:Viable Swine Flu Shot Closer to Reality 9Health News:Viable Swine Flu Shot Closer to Reality 10Health News:Viable Swine Flu Shot Closer to Reality 11Health News:Viable Swine Flu Shot Closer to Reality 12Health News:Viable Swine Flu Shot Closer to Reality 13
The Bledsoe Basic Knee Brace offers a broad range of features that are unmatched by any other brace in its price range. Application of this brace is the easiest of any brace on the market....
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
Comprifix Knee is a comfortable, lightweight, anatomically knitted knee support with an incorporated donut shaped insert for the reduction of pain and swelling....
... Brace features an adjustable extension/flexion stop ... in 10 increments. Adjust without tools. ... the stop pins and reposition them ... washable fabric with Velcro fasteners. All ...
Medicine Products: